Emergent Biosolutions (UK) Today
| 0IGA Stock | 9.52 0.04 0.42% |
Performance2 of 100
| Odds Of DistressLess than 21
|
Emergent Biosolutions is selling for under 9.52 as of the 25th of November 2024; that is 0.42% up since the beginning of the trading day. The stock's lowest day price was 9.38. Emergent Biosolutions has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Emergent Biosolutions are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
Moving against Emergent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Emergent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Emergent Biosolutions' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Emergent Biosolutions or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Joseph Papa |
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) |
Emergent Biosolutions (0IGA) is traded on London Exchange in UK and employs 1,600 people. Emergent Biosolutions is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 42.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Emergent Biosolutions's market, we take the total number of its shares issued and multiply it by Emergent Biosolutions's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Emergent Biosolutions operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 50.95 M outstanding shares.
Emergent Biosolutions generates negative cash flow from operations
Check Emergent Biosolutions Probability Of Bankruptcy
Ownership AllocationEmergent Biosolutions retains a total of 50.95 Million outstanding shares. Over half of Emergent Biosolutions' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Emergent Biosolutions. Please watch out for any change in the institutional holdings of Emergent Biosolutions as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Emergent Ownership Details
Emergent Biosolutions Risk Profiles
Although Emergent Biosolutions' alpha and beta are two of the key measurements used to evaluate Emergent Biosolutions' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.74 | |||
| Semi Deviation | 6.33 | |||
| Standard Deviation | 6.78 | |||
| Variance | 45.99 |
Emergent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Emergent Biosolutions without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Emergent Biosolutions Corporate Management
Elected by the shareholders, the Emergent Biosolutions' board of directors comprises two types of representatives: Emergent Biosolutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emergent. The board's role is to monitor Emergent Biosolutions' management team and ensure that shareholders' interests are well served. Emergent Biosolutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emergent Biosolutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Duatschek | Chief VP | Profile | |
| Jessica Perl | Corporate Counsel | Profile | |
| Jennifer Fox | General Affairs | Profile | |
| Kelly Warfield | Senior Development | Profile | |
| William Hartzel | Senior Bioservices | Profile | |
| Robert Burrows | Vice Relations | Profile |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.